| 1. |
中華醫學會, 中華醫學會雜志社, 中華醫學會全科醫學分會, 等. 肺結核基層診療指南(2018 年). 中華全科醫師雜志, 2019, 18(8): 709-717.
|
| 2. |
Yew WW, Yoshiyama T, Leung CC, et al. Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people. Respirology, 2018, 23(6): 567-575.
|
| 3. |
Li MC, Lee NY, Lee CC, et al. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect, 2014, 47(1): 42-47.
|
| 4. |
To KK, Wong SC, Xu T, et al. Use of nasopharyngeal aspirate for diagnosis of pneumocystis pneumonia. J Clin Microbiol, 2013, 51(5): 1570-1574.
|
| 5. |
孫宇新, 黃慧. CD4 細胞計數不能作為指導自身免疫性及炎癥性疾病患者預防肺孢子菌肺炎的唯一指標. 中華結核和呼吸雜志, 2019, 42(9): 720.
|
| 6. |
陳蕾, 王鳳平, 徐俊馳, 等. 非結核分枝桿菌病實驗室診斷方法分析及臨床應用. 中國實驗診斷學, 2019, 23(6): 935-939.
|
| 7. |
林玲, 劉厚明, 鄧群益, 等. γ 干擾素釋放試驗在肺結核和非結核分枝桿菌肺病鑒別診斷中的應用價值. 中國防癆雜志, 2014, 36(6): 477-481.
|
| 8. |
Oh SJ, Lee JK, Shin OS. Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. Immune Netw, 2019, 19(6): e37.
|
| 9. |
Suk CW, Bai KJ, MC MC, et al. Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient. J Microbiol Immunol Infect, 2015, 48(6): 711-712.
|
| 10. |
劉德義, 馬勝喜, 劉雨婷, 等. 胸腺肽 α1 對重癥肺炎合并膿毒癥患者的療效. 中華醫院感染學雜志, 2019, 29(18): 2771-2774.
|